Edward A. Pesicka - 15 May 2026 Form 4 Insider Report for ACCENDRA HEALTH INC/VA/ (ACH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 May 2026, 08:54:54 UTC
Prior SEC filing
24 Mar 2026
Next SEC filing
12 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Edward A. Pesicka, by Rosemarie France POA

Key filing fact

Edward A. Pesicka filed Form 4 for ACCENDRA HEALTH INC/VA/ (ACH) on 19 May 2026.

Key facts

  • This page summarizes Edward A. Pesicka's Form 4 filing for ACCENDRA HEALTH INC/VA/ (ACH).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 May 2026, 08:54.

Change

  • Previous filing in this sequence was filed on 24 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001439487 Primary reporting owner

Pesicka Edward A

Relationship
President & CEO, Director
Address
ACCENDRA HEALTH, INC., 4435 WATERFRONT DRIVE, GLEN ALLEN
Signature
Edward A. Pesicka, by Rosemarie France POA
Signature date
19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACH transaction

Common Stock

Tax liability

Transaction value
Shares
-17,692
Change %
-1.6%
Price
$3.04*
Shares after
1,072,785
Date
15 May 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .